Drug Profile
DAB389 substance P
Alternative Names: DAB389SP; DAB389substance PLatest Information Update: 21 Jan 2011
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Substance P inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 23 Feb 2000 No-Development-Reported for Cancer in USA (Unknown route)
- 25 Feb 1997 New profile
- 25 Feb 1997 Preclinical development for Cancer in USA (Unknown route)